How red blood cells affect bleeding and oxygen levels in brain hemorrhage patients
Erythrocyte contribution to coagulopathy and cerebral oxygenation after intracerebral hemorrhage
This study is looking at how low levels of red blood cells might affect recovery for people who have had a type of stroke called intracerebral hemorrhage, and it aims to find better ways to help these patients heal and avoid complications.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10907522 on NIH RePORTER |
What this research studies
This research investigates the role of red blood cells in patients who have experienced an intracerebral hemorrhage (ICH), a type of stroke that can lead to severe complications. The study aims to understand how low levels of red blood cells may contribute to ongoing bleeding and reduced oxygen delivery to the brain, which can worsen patient outcomes. By examining the relationship between red blood cell levels, coagulation, and cerebral oxygenation, the research seeks to identify better treatment strategies to prevent complications after ICH. The approach includes analyzing patient data and potentially developing targeted transfusion protocols to improve recovery.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients who have recently experienced an intracerebral hemorrhage and may have low red blood cell levels.
Not a fit: Patients who have not experienced an intracerebral hemorrhage or those with stable red blood cell levels may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment protocols that enhance recovery and reduce complications for patients suffering from intracerebral hemorrhage.
How similar studies have performed: While there is evidence linking low red blood cell levels to poor outcomes in other types of brain injuries, this specific approach in intracerebral hemorrhage is novel and has not been extensively tested.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Roh, David — Columbia University Health Sciences
- Study coordinator: Roh, David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.